Gene Symbol | SERPINB9 |
Entrez ID | 5272 |
Uniprot ID | P50453 |
Description | serpin peptidase inhibitor, clade B (ovalbumin), member 9 |
Chromosomal Location | chr6: 2,887,266-2,903,280 |
Ontology | GO ID | GO Term | Definition | Evidence |
---|---|---|---|---|
BP |
GO:0002448 |
mast cell mediated immunity |
Any process involved in the carrying out of an immune response by a mast cell. |
IEP |
BP |
GO:0006915 |
apoptotic process |
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
IEA |
BP |
GO:0006955 |
immune response |
Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. |
IDA |
BP |
GO:0009617 |
response to bacterium |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium. |
IDA |
BP |
GO:0010628 |
positive regulation of gene expression |
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA (for protein-coding genes) and the translation of that mRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. |
IMP |
BP |
GO:0010951 |
negative regulation of endopeptidase activity |
Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins. |
IMP |
BP |
GO:0033668 |
negative regulation by symbiont of host apoptotic process |
Any process in which an organism stops, prevents, or reduces the frequency, rate or extent of programmed cell death in the host, where programmed cell death proceeds by apoptosis. The host is defined as the larger of the organisms involved in a symbiotic interaction. |
IMP |
BP |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity |
The process of protecting a cell from natural killer cell mediated cytotoxicity. |
IMP |
BP |
GO:0043066 |
negative regulation of apoptotic process |
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
IMP |
BP |
GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process. |
IEA |
BP |
GO:0071391 |
cellular response to estrogen stimulus |
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by an estrogen, C18 steroid hormones that can stimulate the development of female sexual characteristics. |
IEP |
CC |
GO:0005615 |
extracellular space |
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
IDA |
CC |
GO:0005622 |
intracellular |
The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm. |
IDA |
CC |
GO:0005634 |
nucleus |
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
IDA |
CC |
GO:0005737 |
cytoplasm |
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
IDA |
CC |
GO:0005829 |
cytosol |
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
IDA |
CC |
GO:0016020 |
membrane |
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
IDA |
CC |
GO:0070062 |
extracellular exosome |
A membrane-bounded vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
IDA |
MF |
GO:0002020 |
protease binding |
Interacting selectively and non-covalently with any protease or peptidase. |
IPI |
MF |
GO:0004867 |
serine-type endopeptidase inhibitor activity |
Stops, prevents or reduces the activity of serine-type endopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; a serine residue (and a histidine residue) are at the active center of the enzyme. |
IDA |
MF |
GO:0005515 |
protein binding |
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
IPI |
MF |
GO:0043027 |
cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
Stops, prevents or reduces the activity of a cysteine-type endopeptidase involved in the apoptotic process. |
IDA|IMP |
Domain ID | Description |
---|---|
IPR000215 |
Serpin family |
IPR000240 |
Serpin B9/maspin |
IPR023795 |
Serpin, conserved site |
IPR023796 |
Serpin domain |
Pathway ID | Pathway Term | Pathway Source |
---|---|---|
hsa05146 |
Amoebiasis |
KEGG |
UMLS CUI | UMLS Term |
---|---|
C0263454 |
Chloracne |
Pubmed ID | Author | Year | Title |
---|---|---|---|
17148555 |
Wood et al. |
2007 |
Molecular Abnormalities in Oocytes from Women with Polycystic Ovary Syndrome Revealed by Microarray Analysis |
Gene Symbol | Entrez ID | Uniprot ID | Score |
---|---|---|---|
CASP1 |
834 |
P29466 |
0.56 |
CRMP1 |
1400 |
Q14194 |
0.63 |
XRCC6 |
2547 |
P12956 |
0.63 |
TRAF5 |
7188 |
O00463 |
0.63 |
TUBB2A |
7280 |
Q13885 |
0.63 |
UNC119 |
9094 |
Q13432 |
0.63 |
PLEKHM1 |
9842 |
Q9Y4G2 |
0.63 |
SETDB1 |
9869 |
Q15047 |
0.63 |
COPS6 |
10980 |
Q7L5N1 |
0.63 |
C14orf1 |
11161 |
Q9UKR5 |
0.63 |
BRD7 |
29117 |
Q9NPI1 |
0.63 |
MED31 |
51003 |
Q9Y3C7 |
0.63 |
RIF1 |
55183 |
Q5UIP0 |
0.63 |
LRIF1 |
55791 |
Q5T3J3 |
0.63 |
CCDC90B |
60492 |
Q9GZT6 |
0.63 |
RBM48 |
84060 |
Q5RL73 |
0.63 |
IGSF21 |
84966 |
Q96ID5 |
0.63 |
UBR1 |
197131 |
Q8IWV7 |
0.63 |
TUBB2B |
347733 |
Q9BVA1 |
0.63 |
GBP7 |
388646 |
Q8N8V2 |
0.63 |
Q9P078_HUMAN |
N/A |
Q9P078 |
0.63 |
ZHX1 |
11244 |
Q9UKY1 |
0.73 |
PRPF40A |
55660 |
O75400 |
0.73 |
GZMB |
3002 |
P10144 |
0.85 |
CASP4 |
837 |
P49662 |
0.59 |
CD81 |
975 |
P60033 |
0.63 |
CDK2 |
1017 |
P24941 |
0.63 |
ECH1 |
1891 |
Q13011 |
0.63 |
EEF1A1 |
1915 |
P68104 |
0.63 |
GBP2 |
2634 |
P32456 |
0.63 |
GDF9 |
2661 |
O60383 |
0.63 |
MCM2 |
4171 |
P49736 |
0.63 |
TLE1 |
7088 |
Q04724 |
0.63 |
IGSF8 |
93185 |
Q969P0 |
0.63 |
GAPDH |
2597 |
P04406 |
0.73 |
TP53 |
7157 |
P04637 |
0.73 |